Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Latest news
Novosanis brings Colli-Pee UAS FV-5040 with CE mark to the market offering a solution for oncology screening
16/12/2022
Novosanis has received a CE-mark for their Colli-Pee ® with special preservative solution for oncology research applications.
Latest blogpost
Upcoming event
Eurogin 2023
Bilbao, Spain
Novosanis is excited to meet you at EUROGIN, from 8 to 11 February in Bilbao, Spain. We are present with a booth (B07) and will share our newest results in scientific posters and scientific session. Scientific Posters - Jhana Hendrickx -'Home-based self-sampling of first void urine for hrHPV...